MID-VOLUME · HOSP-HEAVY
tobramycin Side Effects
tobramycin (also sold as Tobi, Nebcin) sits MID-VOLUME #219 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 47.5% mention hospitalization (11,066 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 23,287
- FAERS reports
FDA Adverse Event Reporting System extract for tobramycin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
tobramycin: 47.5% mention hospitalization (11,066 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #219 of 524 by FAERS report count.
Mid-book FAERS page for tobramycin (Tobi) (23,287 reports). Signature HOSP-HEAVY. Dominant age band on file: 18-44. Educational reference only.
Counts from the openFDA FAERS extract (2002–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
DEATH leads 1,667 of 23,287 reports
Who reports · age peak 18-44 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 18-44 (4,990 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,764 reports, 11.9%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 1,661 |
| RESPIRATORY FAILURE | 155 |
| PNEUMONIA | 126 |
| RENAL FAILURE | 111 |
| CYSTIC FIBROSIS | 95 |
| DYSPNOEA | 85 |
| PYREXIA | 80 |
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 75 |
| SEPSIS | 74 |
| ACUTE KIDNEY INJURY | 72 |
| SEPTIC SHOCK | 70 |
| CONDITION AGGRAVATED | 69 |
| HYPOTENSION | 68 |
| CARDIAC ARREST | 53 |
| CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 51 |
| MULTI-ORGAN FAILURE | 50 |
| CHRONIC KIDNEY DISEASE | 45 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (11,066, 47.5% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS | 1,310 |
| PNEUMONIA | 1,202 |
| CYSTIC FIBROSIS | 1,016 |
| HOSPITALISATION | 938 |
| DYSPNOEA | 801 |
| CONDITION AGGRAVATED | 607 |
| INFECTION | 550 |
| COUGH | 511 |
| PYREXIA | 487 |
| ACUTE KIDNEY INJURY | 382 |
| MALAISE | 373 |
| PSEUDOMONAS INFECTION | 337 |
| PULMONARY FUNCTION TEST DECREASED | 329 |
| ILL-DEFINED DISORDER | 327 |
| FATIGUE | 285 |
| WEIGHT DECREASED | 283 |
| LUNG DISORDER | 280 |
| NAUSEA | 249 |
How to read tobramycin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 23,287 voluntary reports linked to tobramycin (Tobi, Nebcin), 2002-2025. Death is listed on 2,764 (11.9%). Hospitalization appears on 11,066 (47.5%). Top co-reported indication: Cystic Fibrosis.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 47.5% mention hospitalization (11,066 reports).
Read with tobramycin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 23,107 FAERS cases (Δ 180 lighter vs tobramycin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 23,495 FAERS cases (Δ 208 heavier vs tobramycin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 23,037 FAERS cases (Δ 250 lighter vs tobramycin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 23,683 FAERS cases (Δ 396 heavier vs tobramycin); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's WATCHLIST · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.2 pp vs tobramycin's DEATH-HEAVY): CASELOAD · HOSP-MID.
tobramycin stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload WATCHLIST and the label guide.